Detalhe da pesquisa
1.
Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
Diabetes Obes Metab
; 22(7): 1056-1061, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037699
2.
IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.
Endocr Pract
; 24(5): 446-452, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29847166
3.
Threshold-based insulin-pump interruption for reduction of hypoglycemia.
N Engl J Med
; 369(3): 224-32, 2013 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23789889
4.
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Diabetes Technol Ther
; 24(2): 84-92, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515521
5.
A longitudinal assessment of lipids in youth with type 1 diabetes.
Pediatr Diabetes
; 12(4 Pt 2): 365-71, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21392191
6.
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
JAMA
; 316(13): 1407-1408, 2016 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629148
7.
Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
Expert Rev Med Devices
; 18(10): 909-914, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34528851
8.
Insights from a large observational database of continuous glucose monitoring adoption, insulin pump usage and glycemic control: the CareLink™ database.
Pediatr Endocrinol Rev
; 7 Suppl 3: 413-6, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20877255
9.
Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study.
Diabetes Technol Ther
; 22(1): 48-52, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31418587
10.
Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
Diabetes Technol Ther
; 22(5): 422-427, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697182
11.
Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
Diabetes Technol Ther
; 21(12): 677-681, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385732
12.
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
Lancet Diabetes Endocrinol
; 7(6): 462-472, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047902
13.
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.
Diabetes Technol Ther
; 21(1): 11-19, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30585770
14.
Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion.
J Clin Endocrinol Metab
; 93(12): 4576-99, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18782869
15.
Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
Diabetes Technol Ther
; 10(5): 377-83, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18715214
16.
Relationship of highly sensitive C-reactive protein and lipid levels in adolescents with type 1 diabetes mellitus.
Pediatr Diabetes
; 9(2): 122-6, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18036131
17.
Transition of diabetes care from pediatrics to adulthood.
School Nurse News
; 25(1): 27-9, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18236837
18.
Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes.
Appl Health Econ Health Policy
; 16(5): 675-684, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29936685
19.
Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch.
Diabetes Technol Ther
; 20(10): 689-692, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30160523
20.
Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data.
J Med Econ
; 21(3): 225-230, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28994334